This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia
Blood Cancer Journal Open Access 06 November 2023
-
Establishment and characterization of HXWMF-1: the first mouse fibroblastic tumor cell line derived from leukemia-associated fibroblasts
Cancer Cell International Open Access 19 March 2021
-
Aging and leukemic evolution of hematopoietic stem cells under various stress conditions
Inflammation and Regeneration Open Access 05 November 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 2014; 371: 2477–2487.
Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 2014; 371: 2488–2498.
Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 2014; 20: 1472–1478.
Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 2015; 126: 9–16.
Kasamon YL, Bolanos-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA et al. Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults. J Clin Oncol 2015; 33: 3152–3161.
Fialkow PJ, Thomas ED, Bryant JI, Neiman PE . Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971; 1: 251–255.
Tilson MP, Jones RJ, Sexauer A, Griffin CA, Morsberger LA, Batista DA et al. Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities. Biol Blood Marrow Transplant 2013; 19: 1254–1259.
Yasuda T, Ueno T, Fukumura K, Yamato A, Ando M, Yamaguchi H et al. Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation. Leukemia 2014; 28: 426–428.
Shiozaki H, Yoshinaga K, Kondo T, Imai Y, Shiseki M, Mori N et al. Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source. Bone Marrow Transplant 2014; 49: 102–109.
Wiseman DH . Donor cell leukemia: a review. Biol Blood Marrow Transplant 2011; 17: 771–789.
Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012; 150: 264–278.
Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2012; 44: 23–31.
Shirai CL, Ley JN, White BS, Kim S, Tibbitts J, Shao J et al. Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo. Cancer Cell 2015; 27: 631–643.
Thol F, Suchanek KJ, Koenecke C, Stadler M, Platzbecker U, Thiede C et al. SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia 2013; 27: 2072–2075.
Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012; 366: 1090–1098.
Acknowledgements
This work was supported by grants from the National Institute of Health (P01 CA015396) (RJJ) and (P30 CA006973), Edward P. Evans Foundation (LPG) and the Commonwealth Foundation. Next-generation sequencing was performed with the support of the Next Generation Sequencing Center in the Sidney Kimmel Comprehensive Cancer Center.
Author contributions
LPG, GZ, CDG, GG, WM and RJ designed the study. AED and ML helped with regulatory oversight and data collection. LPG and NT were responsible for clinical data collection. GZ, JE and CDG analyzed the bone marrow morphology, flow cytometric, cytogenetic and bone marrow engraftment data. VY performed next-generation DNA sequencing. RV, GZ and ML performed the statistical analysis. LPG, GZ, WM, CDG and RJ wrote the manuscript, which was edited and approved by all authors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Gondek, L., Zheng, G., Ghiaur, G. et al. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia 30, 1916–1920 (2016). https://doi.org/10.1038/leu.2016.63
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2016.63
This article is cited by
-
Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia
Blood Cancer Journal (2023)
-
Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?
Head and Neck Pathology (2022)
-
Establishment and characterization of HXWMF-1: the first mouse fibroblastic tumor cell line derived from leukemia-associated fibroblasts
Cancer Cell International (2021)
-
Aging and leukemic evolution of hematopoietic stem cells under various stress conditions
Inflammation and Regeneration (2020)
-
The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation
Bone Marrow Transplantation (2020)